Expression of angiogenic and vasculogenic proteins in the lung in alveolar capillary dysplasia/misalignment of pulmonary veins: An immunohistochemical study

Pediatric and Developmental Pathology

Volumn 13, Issue 5, 2010, Pages 354-361

  Sen, Partha ^a   Choudhury, Tiyashi ^a   Smith, E O'Brian ^a   Langston, Claire ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Alveolar capillary dysplasia; Immunohistochemistry; Lung development; Misalignment of pulmonary veins

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENE PRODUCT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VON HIPPEL LINDAU PROTEIN; ACTIVIN RECEPTOR 2; ACVRL1 PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN; VHL PROTEIN, HUMAN;

ALVEOLAR CAPILLARY DYSPLASIA; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC DISORDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LUNG BLOOD VESSEL; LUNG DYSPLASIA; LUNG PARENCHYMA; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY VEIN MALFORMATION; PULMONARY VEIN MISALIGNMENT; BIOSYNTHESIS; CONGENITAL MALFORMATION; GENE EXPRESSION PROFILING; LUNG ALVEOLUS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NEWBORN; PERSISTENT PULMONARY HYPERTENSION; PULMONARY VEIN;

ACTIVIN RECEPTORS, TYPE II; GENE EXPRESSION PROFILING; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PERSISTENT FETAL CIRCULATION SYNDROME; PULMONARY ALVEOLI; PULMONARY VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 79952279056     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/09-04-0640-OA.1     Document Type: Article

References (47)

1. Langston C. Misalignment of pulmonary veins and alveolar capillary dysplasia. Pediatr Pathol 1991;11:163-170.
2. Wagenvoort CA. Misalignment of lung vessels: a syndrome causing persistent neonatal pulmonary hypertension. Hum Pathol 1986;17: 727-730. (Pubitemid 16070411)
3. Al-Hathlol K, Phillips S, Seshia MK, Casiro O, Alvaro RE, Rigatto H. Alveolar capillary dysplasia. Report of a case of prolonged life without extracorporeal membrane oxygenation (ECMO) and review of the literature. Early Hum Dev 2000;57:86-94.
4. Eulmesekian P, Cutz E, Parvez B, Bohn D, Adatia I. Alveolar capillary dysplasia: a six year single center experience. J Perinat Med 2005;33:347-352. (Pubitemid 41205870)
5. Vassal HB, Malone M, Petros AJ, Winter RM. Familial persistent pulmonary hypertension of the newborn resulting from misalignment of the pulmonary vessels (congenital alveolar capillary dysplasia). J Med Genet 1998;35:58-60. (Pubitemid 28156494)
6. Licht C, Schikendantz S, Sreeram N, et al. Prolonged survival in alveolar capillary dysplasia syndrome. Eur J Pediatr 2004;163:181-182. (Pubitemid 38328073)
7. Ahmed S, Ackerman V, Faught P, Langston C. Profound hypoxemia and pulmonary hypertension in a 7 month old: late presentation of alveolar capillary dysplasia. Pediatr Crit Care Med 2008;9:e43-e46.
8. Steinhorn RH, Cox PN, Fineman JR, et al. Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia. J Pediatr 1997;130:417-422. (Pubitemid 27492686)
9. Michalsky MP, Arca MJ, Groenman F, Hammond S, Tibboel D, Caniano DA. Alveolar capillary dysplasia: a logical approach to a fatal disease. J Pediatr Surg 2005;40:1100-1105. (Pubitemid 40966659)
10. Sen P, Thakur N, Stockton DW, Langston C, Bejjani BA. Expanding the phenotype of alveolar capillary dysplasia (ACD). J Pediatr 2004; 145:646-651. (Pubitemid 39440944)
11. Rabah R, Poulik JM. Congenital alveolar capillary dysplasia with misalignment of pulmonary veins associated with hypoplastic left heart. Pediatr Dev Pathol 2001;4:167-174. (Pubitemid 32154975)
12. Simonton S, Chrenka B. Familial persistent pulmonary hypertension in two siblings with phocomelia and alveolar capillary dysplasia (ACD)-a new syndrome? (abstract). Mod Pathol 1993;6:9P.
13. Boggs S, Harris MC, Hoffman DJ, et al. Misalignment of pulmonary veins with alveolar capillary dysplasia: affected siblings and variable phenotypic expression. J Pediatr 1994;124:125-128. (Pubitemid 24027300)
14. Gutierrez C, Rodriguez A, Palenzuela S, Forteza C, Rossello JL. Congenital misalignment of pulmonary veins with alveolar capillary dysplasia causing persistent neonatal pulmonary hypertension: report of two affected siblings. Pediatr Dev Pathol 2000;3:271-276. (Pubitemid 30232853)
15. Pasutto F, Sticht H, Hammersen G, et al. Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation. Am J Hum Genet 2007;80:550-560.
16. Stankiewicz P, Sen P, Bhatt SS, et al. Genomic, genic deletions and point mutations within the FOX transcription factor gene cluster in 16q24.1 result in syndromic or isolated lung developmental disorders. Am J Hum Genet 2009;84:1-12.
17. Young SL, Evans K, Eu JP. Nitric oxide modulates branching morphogenesis in fetal rat lung explants. Am J Physiol Lung Cell Mol Physiol 2002;282:L379-L385. (Pubitemid 34654639)
18. Cooke JP. NO and angiogenesis. Atheroscler Suppl 2003;4:53-60.
19. Fukumura D, Gohongi T, Kadambi A, et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 2001;98:2604-2609. (Pubitemid 32209529)
20. Xue C, Johns RA. Upregulation of nitric oxide synthase correlates temporally with onset of pulmonary vascular remodeling in the hypoxic rat. Hypertension 1996;28:743-753. (Pubitemid 26365513)
21. Kimura H, Esumi H. Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochim Pol 2003;50:49-59. (Pubitemid 37034227)
22. de Rooij JD, Hosgor M, Izjendoorn Y, et al. Expression of angiogenesis-related factors in lungs of patients with congenital diaphragmatic hernia and pulmonary hypoplasia of other causes. Pediatr Dev Pathol 2004;7:468-477. (Pubitemid 40385237)
23. Sherman TS, Chen Z, Yuhanna IS, et al. Nitric oxide synthase isoform expression in the developing lung epithelium. Am J Physiol 1999;276:L383-L390. (Pubitemid 29102281)
24. German Z, Chambliss KL, Pace MC, et al. Molecular basis of cell-specific endothelial nitric oxide synthase expression in airway epithelium. J Biol Chem 2000;275:8183-8189. (Pubitemid 30159734)
25. Shaul PW, North AJ, Wu LC, et al. Endothelial nitric oxide synthase is expressed in cultured human bronchial epithelium. J Clin Invest 1994;94:2231-2236. (Pubitemid 24379593)
26. Tracey WR, Pollock JS, Murad F, et al. Identification of endothelial-like type III NO synthase in LLC-PK1 kidney epithelial cells. Am J Physiol 1994;266:C22-C28.
27. McNaughton L, Puttagunta L, Martinez-Cuesta, et al. Distribution of nitric oxide synthase in normal and cirrhotic human liver. Proc Natl Acad Sci USA 2002;99:17161-17166. (Pubitemid 36034115)
28. Han RN, Stewart DJ. Defective lung vascular development in endothelial nitric oxide deficient mice. Trends Cardiovasc Med 2006;16:29-34. (Pubitemid 43012039)
29. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature 1995; 376:62-66.
30. Rajatapiti P, van der Horst IW, de Rooij JD, et al. Expression of hypoxia-inducible factors in normal human lung development. Pediatr Dev Pathol 2008;11:193-199.
31. Gnarra JR, Ward JM, Porter FD, et al. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci USA 1997;94:9102-9107.
32. George DJ, Kaelin WG. The von Hippel-Lindau protein, vascular endothelial growth factor, and kidney cancer. N Engl J Med 2003; 349:419-421. (Pubitemid 36910018)
33. Bae MK, Jeong JW, Kim SH, et al. Tid-1 interacts with the von Hippel-Lindau protein and modulates angiogenesis by destabilization of HIFa. Cancer Res 2005;65:2520-2525.
34. Goodsell DS. The molecular perspective: VEGF and angiogenesis. Oncologist 2002;7:569-570. (Pubitemid 36009004)
35. Watkins RH, D'Angio CT, Ryan RM, Patel A, Maniscalco WM. Differential expression of VEGF mRNA splice variants in newborn and adult hyperoxic lung injury. Am J Physiol 1999;276:L858-L867. (Pubitemid 29249639)
36. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
37. Acarregui MJ, Penisten ST, Goss KL, Ramirez K, Snyder JM. Vascular endothelial growth factor gene expression in human fetal lung in vitro. Am J Respir Cell Mol Biol 1999;20:14-23. (Pubitemid 129504838)
38. Ng YS, Rohan R, Sunday ME, Demello DE, D'Amore PA. Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn 2001;220:112-121. (Pubitemid 32107812)
39. Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435-439. (Pubitemid 26102719)
40. Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994;90:649-652. (Pubitemid 24242728)
41. Namiki A, Brogi E, Kearney M, et al. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 1995;270:31189-31195. (Pubitemid 26012206)
42. Chen C-H, Lai J-M, Chou T-Y, et al. VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via P13K/AKT pathway. PLoS One 2009;4:e5052.
43. Ferrera N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439-442. (Pubitemid 26102720)
44. Goydos JS, Gorski DH. Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma. Clin Can Res 2003;9:5962-5967. (Pubitemid 38018082)
45. Nowicki M, Konwerska A, Ostalska-Nowicka D, et al. Vascular endothelia growth factor (VEGF)-C - a potent risk factor in children diagnosed with stage 4 neuroblastoma. Folia Histochem Cytobiol 2008;46:493-499.
46. Whittle C, Gillespie K, Harrison R, et al. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF147 mRNA, a novel truncated splice variant. Clin Sci 1999; 97:303-312. (Pubitemid 29425324)
47. Cottin V, Dupuis-Girod S, Lesca G, Cordier JF. Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease). Respiration 2007;74:361-378. (Pubitemid 47093147)